EUVIMEDEUVIMED entdecken
Crossref

Small-Molecule Therapeutics Achieve Multiple Mechanism-Mediated Sensitizations of Colorectal Cancer to Immune Checkpoint Blockade via Neutrophil Micropharmacies

Xiuqi Li, Xuwentai Liu, Meng Wang, Xinyi Zhang, Ziyao Zhang, Lingjing Xue, Qianqian Xu, Juanjuan Ye, Meixi Hao, Can Zhang iD

Nano Letters · 2024

DOI: 10.1021/acs.nanolett.4c03678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2024. Verfasst von Xiuqi Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, Chin…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neutrophils, Immune Checkpoint Inhibitors, Tumor Microenvironment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: State Key Laboratory of Natural Medicines, Natural Science Foundation of Jiangsu Province, Double First Class University Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade (ICB) therapy has been approved for colorectal cancer (CRC). However, response rates are variable and often 4-fold increase in the ratios of the amount of both IRI and GAL accumulated in tumors to the dosage administration, effectively achieving multiple mechanism-mediated sensitization of CRC to ICB therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNeutrophilsImmune Checkpoint InhibitorsTumor MicroenvironmentIrinotecanHumansAnimalsMiceQuinolinesPyrazolesLiposomesCell Line, TumorImmunogenic Cell Death

Stichwörter der Autor:innen

Colorectal cancerCombination immunotherapyImmune checkpoint blockade therapyImmunogenic cell deathNeutrophil micropharmaciesTransforming growth factor-beta inhibitor

Substanzen

Immune Checkpoint InhibitorsIrinotecanQuinolinesLY-2157299PyrazolesLiposomes

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, China.
  • Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China.

ORCID-Profile: Can Zhang

Förderung

  • State Key Laboratory of Natural Medicines
  • Natural Science Foundation of Jiangsu Province
  • Double First Class University Plan
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • Technology innovation project of Nucleic acid drug from National Center of Technology Innovation for Biopharmaceuticals

Zitieren

APA

Li, X., Liu, X., Wang, M., Zhang, X., Zhang, Z., Xue, L., Xu, Q., Ye, J., Hao, M., & Zhang, C. (2024). Small-Molecule Therapeutics Achieve Multiple Mechanism-Mediated Sensitizations of Colorectal Cancer to Immune Checkpoint Blockade via Neutrophil Micropharmacies. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c03678

Vancouver

Li X, Liu X, Wang M, Zhang X, Zhang Z, Xue L, et al. Small-Molecule Therapeutics Achieve Multiple Mechanism-Mediated Sensitizations of Colorectal Cancer to Immune Checkpoint Blockade via Neutrophil Micropharmacies. Nano Letters. 2024. doi:10.1021/acs.nanolett.4c03678

BibTeX
@article{Li2024,
  author = {Li, Xiuqi and Liu, Xuwentai and Wang, Meng and Zhang, Xinyi and Zhang, Ziyao and Xue, Lingjing and Xu, Qianqian and Ye, Juanjuan and Hao, Meixi and Zhang, Can},
  title = {Small-Molecule Therapeutics Achieve Multiple Mechanism-Mediated Sensitizations of Colorectal Cancer to Immune Checkpoint Blockade via Neutrophil Micropharmacies},
  journal = {Nano Letters},
  year = {2024},
  doi = {10.1021/acs.nanolett.4c03678}
}
Kostenlos starten →